Quick Takeaways
- Chris Degnan has 2 issuer positions tracked on this page.
- Estimated disclosed ownership value: $49,118.
- Recent insider filing activity is available below.
Follow Filing Activity
Follow Chris Degnan and return when a new Insider Trading filing changes the record on this page.
This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| URGN | UroGen Pharma Ltd. | Chief Financial Officer | $38,418 | -$37,121 | -49% | 31 Jan 2026 |
| GRTX | Galera Therapeutics, Inc. | Chief Financial Officer | $10,700 | 13 Mar 2023 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|